Leqembi, an Alzheimer’s drug developed by Eisai and Biogen, demonstrates positive effects over a three-year period

Eisai Biogen Alzheimer's drug Leqembi shows benefits over three years

Welcome to Extreme Investor Network, where we bring you the latest and most valuable information in the world of business news. Today, we are diving into the breakthrough Alzheimer’s drug Leqembi and the long-term study … Read more

Stocks are anticipated to enter a ten-year stagnant period with significant losses similar to the dot-com crash, according to a fund manager

Stocks are headed for a decade-long 'dead' zone with losses on par with the dot-com bust, fund manager says

Are you enjoying the current stock market rally? Well, you might want to prepare yourself for a potential shift in tides. According to Bill Smead, a renowned fund manager, the S&P 500 could be facing … Read more